Literature DB >> 14555287

Comparison of effects of Y-27632 and Isoproterenol on release of cytokines from human peripheral T cells.

Masayuki Aihara1, Kunio Dobashi, Kunihiko Iizuka, Tsugio Nakazawa, Masatomo Mori.   

Abstract

Y-27632 selectively inhibits Rho-associated protein kinases (ROCKs), an effector for RhoA. The RhoA system is involved in T cell activation. Y-27632 mimicked effects of beta agonists on human cells. We examined the effects of both Y-27632 and Isoproterenol (Iso) on the release of T helper type 1 (Th-1) cytokines (interleukin (IL)-2 and interferon (IFN)-gamma) and Th-2 cytokines (IL-4 and IL-5) from activated human T cells. Peripheral T cells obtained from seven healthy volunteers were incubated in the presence of Y-27632 (0.1-10 micro M) for 30 min, and stimulated with 50 micro g/ml of Concanavalin A (Con A) for 24 h. Concomitantly, after an incubation with medium alone, cells were stimulated with Con A in the presence of Iso (0.1-10 micro M). The concentration of these cytokines in supernatants was measured by ELISA. Both Y-27632 and Iso suppressed release of Th-1 cytokines, decreased release of Th-2 cytokines weakly, and reduced ratio of Th-1/Th-2 cytokine release from Con A-activated T cells. These inhibitory effects of Y-27632 closely resembled those of Iso at each concentration tested. Y-27632 mimicked effects of Iso on secretion of Th-1 and Th-2 cytokines from human peripheral T cells activated with Con A. It is suggested that the RhoA/ROCK system plays an important role in the release of Th-1 cytokines and is partially involved in the release of Th-2 cytokines from human T cells activated through T cell receptor (TCR).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555287     DOI: 10.1016/S1567-5769(03)00184-X

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

Review 1.  Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.

Authors:  Yuqing Yan; Jiezhong Yu; Ye Gao; Gajendra Kumar; Minfang Guo; Yijin Zhao; Qingli Fang; Huiyu Zhang; Jingwen Yu; Yuqiang Jiang; Han-Ting Zhang; Cun-Gen Ma
Journal:  Metab Brain Dis       Date:  2018-12-14       Impact factor: 3.584

2.  Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency.

Authors:  David I Kasahara; Fernanda M C Ninin; Alison P Wurmbrand; James K Liao; Stephanie A Shore
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

3.  Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65.

Authors:  Hideaki Shimada; Lakshman E Rajagopalan
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

4.  Cardioprotective role of FA against isoproterenol induced cardiac toxicity.

Authors:  Pankaj G Jain; Umesh B Mahajan; Sachin D Shinde; Sanjay J Surana
Journal:  Mol Biol Rep       Date:  2018-08-13       Impact factor: 2.316

5.  Inhalation of the Rho-kinase inhibitor Y-27632 reverses allergen-induced airway hyperresponsiveness after the early and late asthmatic reaction.

Authors:  Dedmer Schaafsma; I Sophie T Bos; Annet B Zuidhof; Johan Zaagsma; Herman Meurs
Journal:  Respir Res       Date:  2006-09-26

Review 6.  The RhoA-ROCK pathway in the regulation of T and B cell responses.

Authors:  Edd Ricker; Luvana Chowdhury; Woelsung Yi; Alessandra B Pernis
Journal:  F1000Res       Date:  2016-09-12

7.  Rho kinase II interference by small hairpin RNA ameliorates 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine‑induced parkinsonism in mice.

Authors:  Qiong Zhang; Yong-Fei Zhao; Jian-Ying Xi; Wen-Bo Yu; Bao-Guo Xiao
Journal:  Mol Med Rep       Date:  2016-10-26       Impact factor: 2.952

8.  Synergistic Effects of Weightlessness, Isoproterenol, and Radiation on DNA Damage Response and Cytokine Production in Immune Cells.

Authors:  Maria Moreno-Villanueva; Alan H Feiveson; Stephanie Krieger; AnneMarie Kay Brinda; Gudrun von Scheven; Alexander Bürkle; Brian Crucian; Honglu Wu
Journal:  Int J Mol Sci       Date:  2018-11-21       Impact factor: 5.923

9.  Eosinophilic inflammation in allergic asthma.

Authors:  Samantha S Possa; Edna A Leick; Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  Front Pharmacol       Date:  2013-04-17       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.